Early Glycan Screening: A Critical Step for High-Quality Biologics Development
In biopharmaceutical production, particularly in the development of therapeutic antibodies, glycosylation is a crucial determinant of product efficacy, stability, and safety. As glycan structures greatly impact critical quality attributes (CQAs) such as immunogenicity, pharmacokinetics, and ... Continued
